Acetylcholine, fatty acids, and lipid mediators are linked to COVID-19 severity (2022)
Pérez, Malena Martínez; Pimentel, Vinícius Eduardo; Fuzo, Carlos Alessandro; Silva Neto, Pedro Vieira da; Toro, Diana Mota; Silva, Thais Fernanda de Campos Fraga da; Gardinassi, Luiz Gustavo Araujo 
; Oliveira, Camilla Narjara Simão; Souza, Camila O. S.; Torre Neto, Nicola T.; Carvalho, Jonatan Constança Silva de; Leo, Thais Canassa de ; Takahashi, Viviani Nardini ; Feitosa, Marley Ribeiro; Parra, Rogério Serafim; Rocha, José Joaquim Ribeiro da ; Féres, Omar; Vilar, Fernando Crivelenti; Gaspar, Gilberto Gambero; Constant, Leticia F.; Ostini, Fátima M.; Degiovani, Augusto Marcussi; Amorim, Alessandro P.; Viana, Angelina Lettiere ; Fernandes, Ana Paula Morais ; Maruyama, Sandra Regina; Russo, Elisa Maria de Sousa ; Santos, Isabel Kinney Ferreira de Miranda; Bonato, Vânia Luiza Deperon; Cardoso, Cristina Ribeiro de Barros; Sorgi, Carlos Arterio ; Dias-Baruffi, Marcelo; Faccioli, Lucia Helena ; Carmona-Garcia, Ingryd; Milanezi, Cristiane Maria; Zaparoli, Kamila; Garbato, Caroline Tempesta; Argolo, Jamille Guedes Malta
Source: The Journal of Immunology. Unidades: FCFRP, FMRP, EERP, FFCLRP, EE/EERP
Subjects: ACETILCOLINA, ÁCIDOS ARAQUIDÔNICOS, COVID-19, ÁCIDOS GRAXOS
ABNT
PÉREZ, Malena Martínez et al. Acetylcholine, fatty acids, and lipid mediators are linked to COVID-19 severity. The Journal of Immunology, v. 209, n. 2, p. 250-261, 2022Tradução . . Disponível em: https://doi.org/10.4049/jimmunol.2200079. Acesso em: 14 nov. 2024.APA
Pérez, M. M., Pimentel, V. E., Fuzo, C. A., Silva Neto, P. V. da, Toro, D. M., Silva, T. F. de C. F. da, et al. (2022). Acetylcholine, fatty acids, and lipid mediators are linked to COVID-19 severity. The Journal of Immunology, 209( 2), 250-261. doi:10.4049/jimmunol.2200079NLM
Pérez MM, Pimentel VE, Fuzo CA, Silva Neto PV da, Toro DM, Silva TF de CF da, Gardinassi LGA, Oliveira CNS, Souza COS, Torre Neto NT, Carvalho JCS de, Leo TC de, Takahashi VN, Feitosa MR, Parra RS, Rocha JJR da, Féres O, Vilar FC, Gaspar GG, Constant LF, Ostini FM, Degiovani AM, Amorim AP, Viana AL, Fernandes APM, Maruyama SR, Russo EM de S, Santos IKF de M, Bonato VLD, Cardoso CR de B, Sorgi CA, Dias-Baruffi M, Faccioli LH, Carmona-Garcia I, Milanezi CM, Zaparoli K, Garbato CT, Argolo JGM. Acetylcholine, fatty acids, and lipid mediators are linked to COVID-19 severity [Internet]. The Journal of Immunology. 2022 ; 209( 2): 250-261.[citado 2024 nov. 14 ] Available from: https://doi.org/10.4049/jimmunol.2200079Vancouver
Pérez MM, Pimentel VE, Fuzo CA, Silva Neto PV da, Toro DM, Silva TF de CF da, Gardinassi LGA, Oliveira CNS, Souza COS, Torre Neto NT, Carvalho JCS de, Leo TC de, Takahashi VN, Feitosa MR, Parra RS, Rocha JJR da, Féres O, Vilar FC, Gaspar GG, Constant LF, Ostini FM, Degiovani AM, Amorim AP, Viana AL, Fernandes APM, Maruyama SR, Russo EM de S, Santos IKF de M, Bonato VLD, Cardoso CR de B, Sorgi CA, Dias-Baruffi M, Faccioli LH, Carmona-Garcia I, Milanezi CM, Zaparoli K, Garbato CT, Argolo JGM. Acetylcholine, fatty acids, and lipid mediators are linked to COVID-19 severity [Internet]. The Journal of Immunology. 2022 ; 209( 2): 250-261.[citado 2024 nov. 14 ] Available from: https://doi.org/10.4049/jimmunol.2200079
